NCT00689403View on ClinicalTrials.gov

Evaluate Different Extended-release (ER) Tablets/Capsules of AZD1305

PHASE1CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Healthy

Interventions

DRUG

AZD1305

Extended release capsules, oral single doses

DRUG

AZD1305

Extended release capsules, oral single doses

Trial Locations (1)

Unknown

Research Site, Harrow

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY